1. Home
  2. LPA vs CYPH Comparison

LPA vs CYPH Comparison

Compare LPA & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LPA

Logistic Properties of the Americas

HOLD

Current Price

$3.51

Market Cap

79.0M

Sector

N/A

ML Signal

HOLD

CYPH

Cypherpunk Technologies Inc.

N/A

Current Price

$1.00

Market Cap

73.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LPA
CYPH
Founded
2013
2011
Country
United States
United States
Employees
N/A
6
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.0M
73.4M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
LPA
CYPH
Price
$3.51
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.9K
2.1M
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.04
$0.50
52 Week High
$9.41
$3.70

Technical Indicators

Market Signals
Indicator
LPA
CYPH
Relative Strength Index (RSI) 58.80 62.70
Support Level $2.92 $0.91
Resistance Level $3.74 $1.14
Average True Range (ATR) 0.23 0.11
MACD -0.02 0.00
Stochastic Oscillator 56.47 68.87

Price Performance

Historical Comparison
LPA
CYPH

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Share on Social Networks: